Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
1.870
+0.030 (1.63%)
At close: Dec 20, 2024, 4:00 PM
1.900
+0.030 (1.60%)
After-hours: Dec 20, 2024, 5:42 PM EST
Allogene Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -283.43 | -327.27 | -340.41 | -182.05 | -316.38 | -184.59 | |
| Depreciation & Amortization | 13.88 | 14.2 | 14.3 | 10.45 | 7.44 | 4.42 | |
| Asset Writedown & Restructuring Costs | 28.96 | 13.25 | - | - | 0.15 | 0.6 | |
| Loss (Gain) From Sale of Investments | -6 | 0.19 | 2.89 | 6.96 | 3.25 | -3.6 | |
| Loss (Gain) on Equity Investments | 4.49 | 10.67 | 12.88 | 4.09 | 67.31 | 0.18 | |
| Stock-Based Compensation | 54.1 | 65.95 | 83.6 | 80.82 | 65.26 | 46.06 | |
| Other Operating Activities | -0.19 | 0.58 | 2.33 | -73.13 | 3.96 | 6.45 | |
| Change in Accounts Payable | -0.84 | -7.5 | 4.87 | -0.77 | 0.62 | -0.99 | |
| Change in Unearned Revenue | -0 | -0 | -0.02 | -38.3 | 38.35 | - | |
| Change in Other Net Operating Assets | -28.3 | -7.8 | -0.95 | 7.12 | 14.96 | -5.89 | |
| Operating Cash Flow | -217.31 | -237.73 | -220.52 | -184.81 | -115.09 | -137.35 | |
| Capital Expenditures | -0.62 | -1.52 | -5.19 | -21.45 | -65.96 | -50.79 | |
| Investment in Securities | 88.83 | 164.81 | 111.35 | 185.1 | -439.17 | 214.88 | |
| Investing Cash Flow | 88.22 | 163.29 | 106.16 | 163.66 | -505.12 | 164.08 | |
| Issuance of Common Stock | 108.81 | 95.7 | 2.95 | 11.96 | 633.59 | 58.96 | |
| Financing Cash Flow | 111.09 | 95.7 | 2.95 | 11.96 | 633.59 | 58.96 | |
| Net Cash Flow | -18.01 | 21.25 | -111.41 | -9.19 | 13.38 | 85.69 | |
| Free Cash Flow | -217.93 | -239.25 | -225.71 | -206.26 | -181.05 | -188.14 | |
| Free Cash Flow Margin | -506806.98% | -251841.05% | -144685.90% | -180.79% | - | - | |
| Free Cash Flow Per Share | -1.18 | -1.52 | -1.58 | -1.52 | -1.50 | -1.86 | |
| Levered Free Cash Flow | -111.51 | -134.26 | -111.74 | -85.97 | -97.89 | -130.06 | |
| Unlevered Free Cash Flow | -111.45 | -134.26 | -111.74 | -85.97 | -97.89 | -130.06 | |
| Change in Net Working Capital | 10.78 | 16.34 | -5.27 | 43.17 | -56.77 | 3.5 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.